Gut microbiota: Red meat & cardiovascular disease
13th Sep, 2022


Cardiovascular disease (CVD) is one of the leading causes of mortality and morbidity worldwide, with an estimated 17.9 million people dying from CVD in 2019, representing 32% of all global deaths (1). 

Various risk factors are known to contribute CVD, including physical inactivity, type 2 diabetes mellitus, age, gender, genetics, tobacco, and alcohol abuse and a Western-style diet. The impact of animal source foods (ASF), including unprocessed red meat, processed meat, fish, poultry and eggs, on CVD has been widely studied. Epidemiological evidence suggests that high intake of processed and unprocessed red meat is associated with CVD, while poultry and fish intake are not (2,3,4). 

Several ingredients and mechanisms have been proposed to explain the potentially harmful effects of red meat intake on CVD. These include contents of saturated fat, cholesterol, haem iron in red meats, sodium, nitrites, and high-temperature cooking of processed meats (5,6,7). However, the mechanisms underlying the potential effects of animal proteins remain unclear. 

Emerging evidence suggests the gut microbiota may be a key factor linking red meat consumption and other modifiable risk factors (e.g. diet, obesity, inactivity and stress) to CVD (8,9,10). Gut microbiota-generated metabolites such as trimethylamine-N-oxide (TMAO) potentially participate in these linkages (11,12). TMAO is generated by microbial metabolism of dietary L-carnitine (abundant almost exclusively in red meat) (13) and choline (present in various ASF) (14). Specific gut microbial enzymes primarily metabolise these dietary precursors to produce high levels of trimethylamine (TMA). TMA is further absorbed into the bloodstream and oxidised in the liver by flavin monooxygenases (FMOs, mainly FMO3) to generate TMAO (12). In addition, two intermediates are also produced by gut microbial metabolism of L-carnitine, and these can be further converted to TMAO (15).

Large-scale clinical cohort studies have demonstrated the association of circulating TMAO with death from cardiometabolic diseases, including diabetes (16), chronic kidney disease (17,18,19), and CVD (20,21,22), and all-cause mortality (23). However, whether TMAO and other metabolites derived from L-carnitine may help explain the effect of red meat intake on cardiovascular risk and to what extent they are involved in the cardiovascular risk of high meat consumption is still unknown.

A recent prospective cohort study of 3,931 adults (>65 years) in the United States investigated ASF intake and TMAO-related metabolites over a median of 12.5 years (15).

After adjusting for sociodemographic factors, lifestyle, dietary factors, and antibiotics use, total meat intake was associated with 22% higher incidence of CVD for every 1.1 serving per day. Nearly eight per cent of this elevated risk was mediated by the levels of the three-gut microbiota-generated metabolites of dietary L-carnitine (TMAO, γ-butyrobetaine, and crotonobetaine).

Higher intake of unprocessed red meat and total ASF were associated with 15% and 18% higher incidence of CVD, respectively. TMAO metabolites significantly mediated these risks by 10.6% and 9.2%, respectively. 

Processed red meat intake was associated with a nonsignificant trend toward higher CVD risk. There were no associations between CVD risk and fish, poultry, and egg consumption.

After evaluating traditional CVD risk factors as mediators, neither blood cholesterol nor blood pressure levels mediated the relationship between CVD risk and total meat consumption. However, factors that significantly mediated the total meat-CVD association included blood glucose (26.1%), insulin (11.8%), and C-reactive protein (6.6%). 

In vitro and animal studies demonstrate that TMAO has several mechanisms that may contribute to CVD:

  • Promotes cholesterol accumulation in macrophages by upregulating cell surface expression of proatherogenic scavenger receptors (24,25).
  • Inhibits reverse cholesterol transport and alters sterol metabolism (13).
  • Induces platelet hyper-reactivity, enhancing thrombotic potential via amplified intracellular Ca2+ release (26).
  • Impairs endothelial function by increasing super-oxide-associated oxidative stress and reducing endothelial nitric oxide synthase activity (27).
  • Enhances vascular inflammation through activation of mitogen-activated protein kinase and nuclear factor-κB signalling (28) and inflammasome activation (29).
  • Inhibits bile acid synthesis, which can trigger an inflammatory response linked to hypercholesterolemia, insulin resistance, atherosclerosis, and heart failure (30,31,32).



The study was observational, and therefore could not control for all risk factors for CVD and may not prove cause and effect between meat consumption and CVD or its mediation by gut microbe-generated chemicals. However, the findings add to the growing evidence linking gut microbiota and CVD and other chronic diseases. 

Furthermore, the study indicates that the higher risk of atherosclerotic CVD associated with red meat intake was also partially mediated by glucose-insulin homeostasis and systematic inflammation. Therefore, dietary changes towards a more plant-based or Mediterranean diet (33,34,35,36,37) and interventions targeting the gut microbiota, such as prebiotics and probiotics (38,39), may be important for modulating TMAO and reducing CVD risk. Future studies are required to test the mechanistic relevance of TMAO in CVD and clarify potential diet and microbiome-targeted therapeutics. 

1World Health Organisation. Cardiovascular disease (CVDs). World Health Organisation, 2022. [cited 2022 Aug 15]. Available from:
2Al-Shaar L, Satija A, Wang DD, Rimm EB, Smith-Warner SA, Stampfer MJ, Hu FB, Willett WC. Red meat intake and risk of coronary heart disease among US men: prospective cohort study. bmj. 2020 Dec 2;371.
3Iqbal R, Dehghan M, Mente A, Rangarajan S, Wielgosz A, Avezum A, Seron P, AlHabib KF, Lopez-Jaramillo P, Swaminathan S, Mohammadifard N. Associations of unprocessed and processed meat intake with mortality and cardiovascular disease in 21 countries [Prospective Urban Rural Epidemiology (PURE) Study]: a prospective cohort study. The American journal of clinical nutrition. 2021 Sep 1;114(3):1049-58.
4Zhong VW, Van Horn L, Greenland P, Carnethon MR, Ning H, Wilkins JT, Lloyd-Jones DM, Allen NB. Associations of processed meat, unprocessed red meat, poultry, or fish intake with incident cardiovascular disease and all-cause mortality. JAMA internal medicine. 2020 Apr 1;180(4):503-12.
5Geiker NR, Bertram HC, Mejborn H, Dragsted LO, Kristensen L, Carrascal JR, Bügel S, Astrup A. Meat and human health—Current knowledge and research gaps. Foods. 2021 Jul 5;10(7):1556.
6Fang X, An P, Wang H, Wang X, Shen X, Li X, Min J, Liu S, Wang F. Dietary intake of heme iron and risk of cardiovascular disease: A dose–response meta-analysis of prospective cohort studies. Nutrition, Metabolism and Cardiovascular Diseases. 2015 Jan 1;25(1):24-35.
7Wolk A. Potential health hazards of eating red meat. Journal of internal medicine. 2017 Feb;281(2):106-22.
8Tang WW, Bäckhed F, Landmesser U, Hazen SL. Intestinal microbiota in cardiovascular health and disease: JACC state-of-the-art review. Journal of the American College of Cardiology. 2019 Apr 30;73(16):2089-105.
9Zhang X, Gérard P. Diet-gut microbiota interactions on cardiovascular disease. Computational and Structural Biotechnology Journal. 2022 Mar 29.
10Papadopoulos PD, Tsigalou C, Valsamaki PN, Konstantinidis TG, Voidarou C, Bezirtzoglou E. The Emerging Role of the Gut Microbiome in Cardiovascular Disease: Current Knowledge and Perspectives. Biomedicines. 2022 May;10(5):948.
11Wang Z, Bergeron N, Levison BS, Li XS, Chiu S, Jia X, Koeth RA, Li L, Wu Y, Tang WW, Krauss RM. Impact of chronic dietary red meat, white meat, or non-meat protein on trimethylamine N-oxide metabolism and renal excretion in healthy men and women. European heart journal. 2019 Feb 14;40(7):583-94.
12Witkowski M, Weeks TL, Hazen SL. Gut microbiota and cardiovascular disease. Circulation research. 2020 Jul 31;127(4):553-70.
13Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, Britt EB, Fu X, Wu Y, Li L, Smith JD. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nature medicine. 2013 May;19(5):576-85.
14Craciun S, Balskus EP. Microbial conversion of choline to trimethylamine requires a glycyl radical enzyme. Proceedings of the National Academy of Sciences. 2012 Dec 26;109(52):21307-12.
15Wang M, Wang Z, Lee Y, Lai HT, de Oliveira Otto MC, Lemaitre RN, Fretts A, Sotoodehnia N, Budoff M, DiDonato JA, McKnight B. Dietary Meat, Trimethylamine N-Oxide-Related Metabolites, and Incident Cardiovascular Disease Among Older Adults: The Cardiovascular Health Study. Arteriosclerosis, Thrombosis, and Vascular Biology. 2022 Sep:ATVBAHA-121.
16Tang WW, Wang Z, Li XS, Fan Y, Li DS, Wu Y, Hazen SL. Increased trimethylamine N-oxide portends high mortality risk independent of glycemic control in patients with type 2 diabetes mellitus. Clinical chemistry. 2017 Jan 1;63(1):297-306.
17Tang WW, Wang Z, Kennedy DJ, Wu Y, Buffa JA, Agatisa-Boyle B, Li XS, Levison BS, Hazen SL. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circulation research. 2015 Jan 30;116(3):448-55.
18Missailidis C, Hällqvist J, Qureshi AR, Barany P, Heimbürger O, Lindholm B, Stenvinkel P, Bergman P. Serum trimethylamine-N-oxide is strongly related to renal function and predicts outcome in chronic kidney disease. PloS one. 2016 Jan 11;11(1):e0141738.
19Stubbs JR, House JA, Ocque AJ, Zhang S, Johnson C, Kimber C, Schmidt K, Gupta A, Wetmore JB, Nolin TD, Spertus JA. Serum trimethylamine-N-oxide is elevated in CKD and correlates with coronary atherosclerosis burden. Journal of the American Society of Nephrology. 2016 Jan 1;27(1):305-13.
20Trøseid M, Ueland T, Hov JR, Svardal A, Gregersen I, Dahl CP, Aakhus S, Gude E, Bjørndal B, Halvorsen B, Karlsen TH. Microbiota‐dependent metabolite trimethylamine‐N‐oxide is associated with disease severity and survival of patients with chronic heart failure. Journal of internal medicine. 2015 Jun;277(6):717-26.
21Senthong V, Wang Z, Li XS, Fan Y, Wu Y, Wilson Tang WH, Hazen SL. Intestinal microbiota‐generated metabolite trimethylamine‐N‐oxide and 5‐year mortality risk in stable coronary artery disease: the contributory role of intestinal microbiota in a COURAGE‐like patient cohort. Journal of the American Heart Association. 2016 Jun 10;5(6):e002816.
22Senthong V, Wang Z, Fan Y, Wu Y, Hazen SL, Tang WW. Trimethylamine N‐oxide and mortality risk in patients with peripheral artery disease. Journal of the American Heart Association. 2016 Oct 19;5(10):e004237.
23Fretts AM, Hazen SL, Jensen P, Budoff M, Sitlani CM, Wang M, de Oliveira Otto MC, DiDonato JA, Lee Y, Psaty BM, Siscovick DS. Association of Trimethylamine N-Oxide and Metabolites With Mortality in Older Adults. JAMA Network Open. 2022 May 2;5(5):e2213242.
24Geng J, Yang C, Wang B, Zhang X, Hu T, Gu Y, Li J. Trimethylamine N-oxide promotes atherosclerosis via CD36-dependent MAPK/JNK pathway. Biomedicine & Pharmacotherapy. 2018 Jan 1;97:941-7.
25Kunjathoor VV, Febbraio M, Podrez EA, Moore KJ, Andersson L, Koehn S, Rhee JS, Silverstein R, Hoff HF, Freeman MW. Scavenger receptors class AI/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. Journal of Biological Chemistry. 2002 Dec 20;277(51):49982-8.
26Zhu W, Gregory JC, Org E, Buffa JA, Gupta N, Wang Z, Li L, Fu X, Wu Y, Mehrabian M, Sartor RB. Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell. 2016 Mar 24;165(1):111-24.
27Brunt VE, Gioscia-Ryan RA, Casso AG, VanDongen NS, Ziemba BP, Sapinsley ZJ, Richey JJ, Zigler MC, Neilson AP, Davy KP, Seals DR. Trimethylamine-N-oxide promotes age-related vascular oxidative stress and endothelial dysfunction in mice and healthy humans. Hypertension. 2020 Jul;76(1):101-12.
28Seldin MM, Meng Y, Qi H, Zhu W, Wang Z, Hazen SL, Lusis AJ, Shih DM. Trimethylamine N‐oxide promotes vascular inflammation through signaling of mitogen‐activated protein kinase and nuclear factor‐κB. Journal of the American Heart Association. 2016 Feb 22;5(2):e002767.
29Zhang X, Li Y, Yang P, Liu X, Lu L, Chen Y, Zhong X, Li Z, Liu H, Ou C, Yan J. Trimethylamine-N-oxide promotes vascular calcification through activation of NLRP3 (nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3) inflammasome and NF-κB (nuclear factor κB) signals. Arteriosclerosis, thrombosis, and vascular biology. 2020 Mar;40(3):751-65.
30Choucair I, Nemet I, Li L, Cole MA, Skye SM, Kirsop JD, Fischbach MA, Gogonea V, Brown JM, Tang WW, Hazen SL. Quantification of bile acids: a mass spectrometry platform for studying gut microbe connection to metabolic diseases [S]. Journal of lipid research. 2020 Feb 1;61(2):159-77.
31Ridlon JM, Harris SC, Bhowmik S, Kang DJ, Hylemon PB. Consequences of bile salt biotransformations by intestinal bacteria. Gut microbes. 2016 Jan 2;7(1):22-39.
32Mayerhofer CC, Ueland T, Broch K, Vincent RP, Cross GF, Dahl CP, Aukrust P, Gullestad L, Hov JR, Trøseid M. Increased secondary/primary bile acid ratio in chronic heart failure. Journal of cardiac failure. 2017 Sep 1;23(9):666-71.
33Krznaric Ž, Bender DV, Meštrovic T. The Mediterranean diet and its association with selected gut bacteria. Current Opinion in Clinical Nutrition & Metabolic Care. 2019 Sep 1;22(5):401.
34Garcia-Mantrana I, Selma-Royo M, Alcantara C, Collado MC. Shifts on gut microbiota associated to mediterranean diet adherence and specific dietary intakes on general adult population. Frontiers in microbiology. 2018 May 7;9:890.
35De Angelis M, Garruti G, Minervini F, Bonfrate L, Portincasa P, Gobbetti M. The food-gut human axis: the effects of diet on gut microbiota and metabolome. Current Medicinal Chemistry. 2019 Jun 1;26(19):3567-83.
36Thomas MS, Fernandez ML. Trimethylamine N-oxide (TMAO), diet and cardiovascular disease. Current Atherosclerosis Reports. 2021 Apr;23(4):1-7.
37Lombardo M, Aulisa G, Marcon D, Rizzo G. The Influence of Animal-or Plant-Based Diets on Blood and Urine Trimethylamine-N-Oxide (TMAO) Levels in Humans. Current Nutrition Reports. 2022 Jan 6:1-3.
38Moludi J, Khedmatgozar H, Nachvak SM, Abdollahzad H, Moradinazar M, Sadeghpour tabaei A. The effects of co-administration of probiotics and prebiotics on chronic inflammation, and depression symptoms in patients with coronary artery diseases: a randomized clinical trial. Nutritional Neuroscience. 2021 Feb 19:1-0.
39Wu H, Chiou J. Potential benefits of probiotics and prebiotics for coronary heart disease and stroke. Nutrients. 2021 Aug 21;13(8):2878.